• Signaling Centers Shape Cell Fate in Mesodermal Organoids

  2026-07-16

  Skoufa et al. introduce a 3D mesodermal organoid model from mESCs that recapitulates limb bud-like spatial patterning and cell fate decisions, revealing how apical-ectodermal ridge (AER)-like signaling centers coordinate tissue organization. This work provides a valuable in vitro platform for dissecting epithelial-mesodermal interactions underlying vertebrate morphogenesis.

• 2X HyperFusion High-Fidelity Master Mix: Precision for Cloni

  2026-07-16

  Unlock robust, ultra-accurate DNA amplification with the 2X HyperFusion High-Fidelity Master Mix, optimized for challenging cloning and CRISPR/Cas9 applications. This high-fidelity master mix delivers low error rates and blunt-end products, streamlining advanced molecular workflows and solving persistent PCR challenges.

• Reelin–Apoer2–Src Signaling: Gatekeeper of Ketamine's Antide

  2026-07-15

  This study uncovers the essential role of synaptic Reelin signaling—particularly via Apoer2 and Src family kinases—in enabling ketamine-induced synaptic plasticity and antidepressant behaviors. Disruption of this pathway blocks ketamine's efficacy, offering a mechanistic explanation for nonresponse in treatment-resistant depression and guiding future neuropsychiatric research.

• S Tag Peptide (A6007): Technical Guide for Protein Tagging

  2026-07-15

  S Tag Peptide addresses common challenges in recombinant protein detection, purification, and solubility enhancement workflows by serving as a versatile and highly soluble fusion tag. It is best suited for applications requiring robust affinity purification and antibody-based detection, but is not intended for systems dependent on independent peptide folding or direct enzymatic activity.

• CCG-1423: RhoA Inhibitor Workflows for Cancer & Viral Resear

  2026-07-14

  CCG-1423 from APExBIO stands out as a potent RhoA inhibitor, uniquely enabling precise dissection of RhoA/ROCK signaling in both cancer and viral pathogenesis workflows. This article delivers advanced use-cases, stepwise experimental guidance, and troubleshooting strategies for maximizing the translational impact of CCG-1423 in cellular assays.

• CHIR-99021 (CT99021): Precision GSK-3 Inhibition in 3D Neuro

  2026-07-14

  Explore the advanced application of CHIR-99021 (CT99021) in engineering physiologically relevant 3D neurovascular co-culture systems. This article uniquely connects selective GSK-3 inhibition to breakthroughs in stem cell differentiation and CNS modeling.

• Pol II Degradation Triggers Apoptosis Beyond Transcription L

  2026-07-13

  The referenced study demonstrates that targeted degradation of RNA Polymerase II induces apoptosis in tumor cells independently of transcriptional shutdown. This discovery reframes the mechanistic link between Pol II inhibition and cell death, with implications for designing apoptosis-focused cancer research assays.

• Applied Use Cases for DIDS (4,4'-Diisothiocyanostilbene-2,2'

  2026-07-13

  DIDS stands out as a gold-standard chloride channel inhibitor, enabling high-fidelity interrogation of ion transport and metastasis mechanisms in cancer, neuroprotection, and vascular biology. This article translates recent reference breakthroughs into actionable workflows, troubleshooting strategies, and advanced applications for APExBIO’s DIDS, with a focus on experimental rigor and translational impact.

• c-Myc tag Peptide in Transcription Factor Regulation: Deep M

  2026-07-12

  Unlock the advanced mechanisms of c-Myc tag Peptide in transcription factor regulation and immunoassay innovation. This article offers a scientific deep dive, connecting c-Myc peptide biochemistry with autophagy and innate immune signaling for next-level assay design.

• Reelin-Apoer2-SFK Pathway: Permissive Gate for Ketamine Acti

  2026-07-10

  This study reveals that intact Reelin-Apoer2-SFK signaling is essential for ketamine-induced synaptic and behavioral antidepressant effects. Disruption of any component in this pathway impairs ketamine’s efficacy, providing mechanistic insights into nonresponsiveness in treatment-resistant depression and highlighting new experimental targets.

• Dacomitinib (PF-00299804): Pan-HER Inhibition and Mitochondr

  2026-07-09

  Explore how Dacomitinib (PF-00299804) uniquely bridges pan-HER inhibition with mitochondrial signaling and apoptosis induction in cancer cells. This article offers advanced insights into protocol optimization and the interplay between EGFR signaling and ferroptosis resistance, setting it apart from standard reviews.

• Optimizing Exosome Research with GW 4869 (hydrochloride hydr

  2026-07-09

  This article examines practical laboratory challenges in exosome and cell injury research, illustrating how GW 4869 (hydrochloride hydrate) (SKU C4769) provides reproducible, data-driven solutions. Scenario-driven Q&A blocks address protocol design, assay optimization, and product reliability, with evidence from recent lupus nephritis studies and vendor comparisons. Researchers gain actionable insight into workflow improvements using GW 4869 (hydrochloride hydrate).

• Ibrexafungerp Activity at Acidic pH Against Resistant Candid

  2026-07-08

  This study rigorously evaluated ibrexafungerp's antifungal activity against both fluconazole-susceptible and -resistant Candida isolates from women with vulvovaginal candidiasis (VVC), specifically under acidic conditions characteristic of the vaginal environment. The key finding is that ibrexafungerp maintains potent in vitro efficacy at low pH, highlighting its potential for addressing treatment gaps in resistant VVC.

• Strategic Use of Bafilomycin A1: Bridging Mechanism and Tran

  2026-07-08

  This article delivers a thought-leadership perspective on Bafilomycin A1, focusing on its mechanistic precision as a V-ATPase inhibitor and its strategic value for translational researchers. Integrating direct evidence, competitive analysis, and actionable guidance, it addresses experimental design, cross-domain relevance, and future directions in lysosomal, bone, and cancer biology.

• Reelin-SFK Pathway Requirement for Ketamine’s Antidepressant

  2026-07-07

  This study reveals that intact synaptic Reelin-Apoer2-Src family kinase (SFK) signaling is essential for ketamine-induced synaptic plasticity and antidepressant-like behavioral responses in mice. The findings clarify mechanistic reasons for ketamine nonresponsiveness in treatment-resistant depression, highlighting the importance of baseline NMDA receptor function maintained by this pathway.

3702 records 7/247 page Previous Next First page 上5页 678910 下5页 Last page